103 related articles for article (PubMed ID: 2454720)
1. Complements as new diagnostic tools of hepatocellular carcinoma in cirrhotic patients.
Chang WY; Chuang WL
Cancer; 1988 Jul; 62(2):227-32. PubMed ID: 2454720
[TBL] [Abstract][Full Text] [Related]
2. The biological significance of serum complements C3 and C4 in HCV-related chronic liver diseases and hepatocellular carcinoma.
Ali OS; Abo-Shadi MA; Hammad LN
Egypt J Immunol; 2005; 12(2):91-9. PubMed ID: 17977214
[TBL] [Abstract][Full Text] [Related]
3. [A clinical study of complements as a marker of a hepatocellular carcinoma].
Takezaki E; Murakami S; Nishibayashi H; Kagawa K; Ohmori H
Gan No Rinsho; 1990 Oct; 36(12):2119-22. PubMed ID: 1700167
[TBL] [Abstract][Full Text] [Related]
4. Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Tsai JF; Tsai JH; Chang WY
Gastroenterol Jpn; 1990 Jun; 25(3):388-93. PubMed ID: 1694150
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non-cirrhotic patients.
Lin MT; Chen CL; Wang CC; Cheng YF; Eng HL; Wang JH; Chiu KW; Lee CM; Hu TH
J Gastroenterol Hepatol; 2011 Apr; 26(4):745-50. PubMed ID: 21418303
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of transiently elevated serum AFP level in developing hepatocellular carcinoma in HBsAg positive-liver cirrhosis].
Lee HY; Jung JH; Kang YS; Kim YS; Moon HS; Park KO; Lee YS; Kim SM; Seo SW; Lee SW; Kim SH; Lee BS; Kim NJ
Korean J Gastroenterol; 2004 Apr; 43(4):252-9. PubMed ID: 15100489
[TBL] [Abstract][Full Text] [Related]
8. A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.
Shimauchi Y; Tanaka M; Kuromatsu R; Ogata R; Tateishi Y; Itano S; Ono N; Yutani S; Nagamatsu H; Matsugaki S; Yamasaki S; Tanikawa K; Sata M
Oncol Rep; 2000; 7(2):249-56. PubMed ID: 10671666
[TBL] [Abstract][Full Text] [Related]
9. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
11. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
[TBL] [Abstract][Full Text] [Related]
13. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
14. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
[TBL] [Abstract][Full Text] [Related]
15. Screening for hepatocellular carcinoma in patients with advanced cirrhosis.
Chalasani N; Horlander JC; Said A; Hoen H; Kopecky KK; Stockberger SM; Manam R; Kwo PY; Lumeng L
Am J Gastroenterol; 1999 Oct; 94(10):2988-93. PubMed ID: 10520857
[TBL] [Abstract][Full Text] [Related]
16. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis.
Sarwar S; Khan AA; Tarique S
J Coll Physicians Surg Pak; 2014 Jan; 24(1):18-22. PubMed ID: 24411536
[TBL] [Abstract][Full Text] [Related]
17. Serum insulin-like growth factor-II and alpha-fetoprotein as tumor markers of hepatocellular carcinoma.
Tsai JF; Jeng JE; Chuang LY; You HL; Ho MS; Lai CS; Wang LY; Hsieh MY; Chen SC; Chuang WL; Lin ZY; Yu ML; Dai CY
Tumour Biol; 2003; 24(6):291-8. PubMed ID: 15004489
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of serum haptoglobin protein as hepatocellular carcinoma candidate marker complementary to α fetoprotein.
Shu H; Kang X; Guo K; Li S; Li M; Sun L; Gan L; Liu Y; Qin X
Oncol Rep; 2010 Nov; 24(5):1271-6. PubMed ID: 20878120
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Role of Blood Tumor Markers in Predicting Hepatocellular Carcinoma in Liver Cirrhosis Patients Undergoing Liver Transplantation.
Kim Y; Park YH; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Lee SG
Ann Transplant; 2016 Oct; 21():660-667. PubMed ID: 27777395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
